Tenofovir disoproxil fumarate in severe acute hepatitis B
Abstract
Background and aim: Acute hepatitis B can progress to liver failure in about 1% of patients who may require liver transplantation. Lamivudine has been shown to be able to prevent acute liver failure and liver transplantation when administered early enough on the course of disease. Very recently, data on tenofovir disoproxil fumarate (TDF) were presented suggesting that this drug is one of the most promising alternatives for patients with chronic...
Paper Details
Title
Tenofovir disoproxil fumarate in severe acute hepatitis B
Published Date
Jan 1, 2008
Volume
46
Issue
01
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History